Software - Application
Compare Stocks
2 / 10Stock Comparison
MANH vs NCNO
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
MANH vs NCNO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Software - Application | Software - Application |
| Market Cap | $8.16B | $2.07B |
| Revenue (TTM) | $1.10B | $586M |
| Net Income (TTM) | $217M | $-22M |
| Gross Margin | 55.6% | 60.1% |
| Operating Margin | 25.6% | -0.8% |
| Forward P/E | 25.7x | 19.3x |
| Total Debt | $112M | $237M |
| Cash & Equiv. | $329M | $121M |
MANH vs NCNO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 20 | May 26 | Return |
|---|---|---|---|
| Manhattan Associate… (MANH) | 100 | 143.9 | +43.9% |
| nCino, Inc. (NCNO) | 100 | 22.0 | -78.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MANH vs NCNO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MANH has the current edge in this matchup, primarily because of its strength in income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 1.10
- 135.2% 10Y total return vs NCNO's -81.0%
- Lower volatility, beta 1.10, Low D/E 35.7%, current ratio 1.28x
NCNO is the clearest fit if your priority is growth exposure.
- Rev growth 13.5%, EPS growth 13.2%, 3Y rev CAGR 25.4%
- 13.5% revenue growth vs MANH's 3.7%
- Lower P/E (19.3x vs 25.7x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.5% revenue growth vs MANH's 3.7% | |
| Value | Lower P/E (19.3x vs 25.7x) | |
| Quality / Margins | 19.7% margin vs NCNO's -3.7% | |
| Stability / Safety | Beta 1.10 vs NCNO's 1.18 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -21.3% vs MANH's -24.6% | |
| Efficiency (ROA) | 28.0% ROA vs NCNO's -1.4%, ROIC 236.8% vs -1.2% |
MANH vs NCNO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MANH vs NCNO — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — MANH and NCNO each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MANH is the larger business by revenue, generating $1.1B annually — 1.9x NCNO's $586M. MANH is the more profitable business, keeping 19.7% of every revenue dollar as net income compared to NCNO's -3.7%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.1B | $586M |
| EBITDAEarnings before interest/tax | $288M | $27M |
| Net IncomeAfter-tax profit | $217M | -$22M |
| Free Cash FlowCash after capex | $380M | $60M |
| Gross MarginGross profit ÷ Revenue | +55.6% | +60.1% |
| Operating MarginEBIT ÷ Revenue | +25.6% | -0.8% |
| Net MarginNet income ÷ Revenue | +19.7% | -3.7% |
| FCF MarginFCF ÷ Revenue | +34.5% | +10.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.4% | +9.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.5% | +2.3% |
Valuation Metrics
NCNO leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, MANH's 27.5x EV/EBITDA is more attractive than NCNO's 119.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $8.2B | $2.1B |
| Enterprise ValueMkt cap + debt − cash | $7.9B | $2.2B |
| Trailing P/EPrice ÷ TTM EPS | 38.28x | -52.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 25.72x | 19.26x |
| PEG RatioP/E ÷ EPS growth rate | 1.78x | — |
| EV / EBITDAEnterprise value multiple | 27.49x | 119.76x |
| Price / SalesMarket cap ÷ Revenue | 7.55x | 3.82x |
| Price / BookPrice ÷ Book value/share | 26.73x | 1.83x |
| Price / FCFMarket cap ÷ FCF | 21.83x | 38.69x |
Profitability & Efficiency
MANH leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
MANH delivers a 78.2% return on equity — every $100 of shareholder capital generates $78 in annual profit, vs $-2 for NCNO. NCNO carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to MANH's 0.36x. On the Piotroski fundamental quality scale (0–9), MANH scores 6/9 vs NCNO's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +78.2% | -2.1% |
| ROA (TTM)Return on assets | +28.0% | -1.4% |
| ROICReturn on invested capital | +2.4% | -1.2% |
| ROCEReturn on capital employed | +76.3% | -1.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.36x | 0.22x |
| Net DebtTotal debt minus cash | -$216M | $116M |
| Cash & Equiv.Liquid assets | $329M | $121M |
| Total DebtShort + long-term debt | $112M | $237M |
| Interest CoverageEBIT ÷ Interest expense | — | -0.51x |
Total Returns (Dividends Reinvested)
MANH leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MANH five years ago would be worth $10,433 today (with dividends reinvested), compared to $3,088 for NCNO. Over the past 12 months, NCNO leads with a -21.3% total return vs MANH's -24.6%. The 3-year compound annual growth rate (CAGR) favors MANH at -6.7% vs NCNO's -8.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -17.6% | -29.2% |
| 1-Year ReturnPast 12 months | -24.6% | -21.3% |
| 3-Year ReturnCumulative with dividends | -18.7% | -22.5% |
| 5-Year ReturnCumulative with dividends | +4.3% | -69.1% |
| 10-Year ReturnCumulative with dividends | +135.2% | -81.0% |
| CAGR (3Y)Annualised 3-year return | -6.7% | -8.2% |
Risk & Volatility
MANH leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MANH is the less volatile stock with a 1.10 beta — it tends to amplify market swings less than NCNO's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MANH currently trades 55.7% from its 52-week high vs NCNO's 51.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 1.18x |
| 52-Week HighHighest price in past year | $247.22 | $33.92 |
| 52-Week LowLowest price in past year | $119.06 | $13.80 |
| % of 52W HighCurrent price vs 52-week peak | +55.7% | +51.4% |
| RSI (14)Momentum oscillator 0–100 | 55.1 | 55.9 |
| Avg Volume (50D)Average daily shares traded | 674K | 2.7M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates MANH as "Buy" and NCNO as "Buy". Consensus price targets imply 85.4% upside for NCNO (target: $32) vs 43.1% for MANH (target: $197).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $197.25 | $32.33 |
| # AnalystsCovering analysts | 15 | 23 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 2 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.9% | 0.0% |
MANH leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). NCNO leads in 1 (Valuation Metrics). 1 tied.
MANH vs NCNO: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is MANH or NCNO a better buy right now?
For growth investors, nCino, Inc.
(NCNO) is the stronger pick with 13. 5% revenue growth year-over-year, versus 3. 7% for Manhattan Associates, Inc. (MANH). Manhattan Associates, Inc. (MANH) offers the better valuation at 38. 3x trailing P/E (25. 7x forward), making it the more compelling value choice. Analysts rate Manhattan Associates, Inc. (MANH) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MANH or NCNO?
On forward P/E, nCino, Inc.
is actually cheaper at 19. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — MANH or NCNO?
Over the past 5 years, Manhattan Associates, Inc.
(MANH) delivered a total return of +4. 3%, compared to -69. 1% for nCino, Inc. (NCNO). Over 10 years, the gap is even starker: MANH returned +135. 2% versus NCNO's -81. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MANH or NCNO?
By beta (market sensitivity over 5 years), Manhattan Associates, Inc.
(MANH) is the lower-risk stock at 1. 10β versus nCino, Inc. 's 1. 18β — meaning NCNO is approximately 8% more volatile than MANH relative to the S&P 500. On balance sheet safety, nCino, Inc. (NCNO) carries a lower debt/equity ratio of 22% versus 36% for Manhattan Associates, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MANH or NCNO?
By revenue growth (latest reported year), nCino, Inc.
(NCNO) is pulling ahead at 13. 5% versus 3. 7% for Manhattan Associates, Inc. (MANH). On earnings-per-share growth, the picture is similar: nCino, Inc. grew EPS 13. 2% year-over-year, compared to 2. 6% for Manhattan Associates, Inc.. Over a 3-year CAGR, NCNO leads at 25. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MANH or NCNO?
Manhattan Associates, Inc.
(MANH) is the more profitable company, earning 20. 3% net margin versus -7. 0% for nCino, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MANH leads at 26. 1% versus -3. 4% for NCNO. At the gross margin level — before operating expenses — NCNO leads at 60. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MANH or NCNO more undervalued right now?
On forward earnings alone, nCino, Inc.
(NCNO) trades at 19. 3x forward P/E versus 25. 7x for Manhattan Associates, Inc. — 6. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NCNO: 85. 4% to $32. 33.
08Which pays a better dividend — MANH or NCNO?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is MANH or NCNO better for a retirement portfolio?
For long-horizon retirement investors, Manhattan Associates, Inc.
(MANH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 10), +135. 2% 10Y return). Both have compounded well over 10 years (MANH: +135. 2%, NCNO: -81. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MANH and NCNO?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.